Patents Assigned to Jiangsu Medolution Ltd.
  • SUBSTITUTED PYRAZOLOPYRIMIDINES AS KINASES INHIBITORS
    Publication number: 20160120868
    Abstract: The present invention is directed to novel pyrazolopyrimidines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities against BTK and/or EGFR T790M and are useful for the treatment of protein kinases mediated diseases and conditions.
    Type: Application
    Filed: May 21, 2014
    Publication date: May 5, 2016
    Applicant: Jiangsu Medolution Ltd.
    Inventor: Dawei ZHANG